Drug Type Small molecule drug |
Synonyms + [1] |
Target |
Action inhibitors |
Mechanism LpxC inhibitors(UDP-3-O-acyl-N-acetylglucosamine deacetylase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC23H25N3O6 |
InChIKeyXYGACYZKHBVOLP-XXBNENTESA-N |
CAS Registry1628207-48-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Respiratory Tract Infections | Phase 2 | United States | 15 Jan 2019 | |
Bacterial Infections | Phase 1 | - | - |